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Abstract
Background: Non-invasive 3-dimensional (3D) ultrasound (US) has emerged as the predominant
approach for evaluating the progression of carotid atherosclerosis and its response to treatment.
The aim of this study was to investigate the quality of a central reading procedure concerning
plaque volume (PV), measured by 3D US in a multinational US trial.
Methods: Two data sets of 45 and 60 3D US patient images of plaques (mean PV, 71.8 and 39.8
μl, respectively) were used. PV was assessed by means of manual planimetry. The intraclass
correlation coefficient (ICC) was applied to determine reader variabilities. The repeatability
coefficient (RC) and the coefficient of variation (CV) were used to investigate the effect of number
of slices (S) in manual planimetry and plaque size on measurement variability.
Results: Intra-reader variability was small as reflected by ICCs of 0.985, 0.967 and 0.969 for 3
appointed readers. The ICC value generated between the 3 readers was 0.964, indicating that inter-
reader variability was small, too. Subgroup analyses showed that both intra- and inter-reader
variabilities were lower for larger than for smaller plaques. Mean CVs were similar for the 5S- and
10S-methods with a RC of 4.7 μl. The RC between both methods as well as the CVs were
comparatively lower for larger plaques.
Conclusion: By implementing standardised central 3D US reading protocols and strict quality
control procedures highly reliable ultrasonic re-readings of plaque images can be achieved in large
multicentre trials.
Introduction
Measurement of carotid atherosclerosis burden and pro-
gression is an important tool for research and patient
management [1]. 2-dimensional (2D) B-mode ultrasound
(US) has been shown to be a sensitive and reproducible
method to detect pre intrusive thickening of artery walls
and to measure intima-media thickness (IMT) in the
carotid artery [2,3]. Ultrasonographically determined IMT
has been used as a marker of atherosclerosis elsewhere in
the arterial system and randomised imaging studies have
examined the effects of blood pressure- and lipid-lower-
ing therapies on carotid IMT changes [4]. The atherogenic
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nature of IMT, however, is uncertain, since 2D US does
not measure medial and intimal thickness separately [5].
An increase in IMT may be the result of an adapted
response of medial layer (remodelling) to tensile (hyper-
tensive) stress or intimal thickening reflecting early
atherosclerosis [6]. Atherosclerotic plaque volume
assessed by 3-dimensional (3D) US [7] may represent a
more reliable measure of atherosclerosis than IMT [8] and
more recently non-invasive 3D US imaging has ermerged
as the predominant approach for evaluating the progres-
sion of carotid atherosclerosis [1,9-12]. 3D US provides a
precise and reproducible method for determining the
change in atherosclerotic plaque volume during treatment
[1,8,10]. A recent randomised trial in hypertensive
patients using carotid 3D US has successfully investigated
the effects of two different classes of antihypertensive
agents on plaque volume changes and demonstrated the
suitability of the 3D US method for tracking progression
or regression of plaque volume over time [13].
3D US measurement of PV within a multicentre clinical
trial setting typically involves processing of data obtained
at more than one investigational site. It is important to
ensure that analysis of the data, and re-reading of the 3D
US images of plaque is carried out in a centralised, stand-
ardised and reproducible manner. The primary aim of this
study was to assess reliability of a central re-reading proce-
dure implemented in a multinational 3D US trial by
determining intra- and inter-reader variabilities and major
factors influencing reading precision.
Materials and methods
The study was performed in accordance with the princi-
ples of the Declaration of Helsinki, and the regulatory
requirements of the International Conference on Harmo-
nisation Guidelines on Good Clinical Practice.
The protocol was approved by the appropriate Institu-
tional Review Board or Ethics Committee at each centre
involved.
All patients gave written informed consent for publication
of this report and accompanying images.
Patients
Two data sets of 45 and 60 3D US carotid plaque images
were obtained from 45 patients (32 men; mean [SD] age,
62.2 [6.9] years) and 60 patients (50 men; mean [SD] age,
61.3 [8.1] years), respectively, who had been followed up
in the ACAT Inhibition Plaque Regression Study (APRES).
The APRES was a multicentre European ultrasound trial,
and participants were recruited at 31 clinical centers
throughout the Czech Republic, Germany, Italy and
Poland. The study assessed the effect of an ACAT-inhibitor
as compared to placebo on carotid plaque volume (Data
on file at Daiichi Sankyo, Munich, Germany). To be eligi-
ble for inclusion in the APRES, patients with defined car-
diovascular risk had to have an increased common carotid
artery (CCA) intima-media thickness (IMT) of > 0.8 mm,
and at least one atherosclerotic plaque in the CCA or the
carotid bulb without marked mineralisation (plaque vol-
ume between 20 and 500 μl).
Ultrasound measurement of plaque volume (PV)
Ultrasound measurements of PV had been carried out by
trained and certified sonographers at 14 ultrasound refer-
ral centers using a high-resolution Voluson 530 D MT,
2D-/3D CFM-Ultrasound System (Kretz-Technik AG, Zipf,
Austria; the equipment is commercially available from General
Electric, GE Ultraschall Deutschland GmbH/D-42655 Solin-
gen and named Logiq 7 BT07) equipped with a mechanical
10 MHz sector motor-driven 3D-probe that provided an
axial resolution of 0.1 mm. An integrated 6.9 MHz Dop-
pler system was used to determine the grade of possible
stenoses.
Small depth of Sweep Box for 3D image acquisition with
an angle of 45° and slow acquisition time of volume scan
were additional features of the ultrasound system. To
measure PV, a longitudinal scan of the common carotid
artery or bulb was carried out followed by volume acqui-
sition. Volume acquisition used 3 orthogonal sectional
planes (A, B, C) and started with the sectional image (A),
which gave a 2D image showing the longitudinal view of
the vessel. Images B and C showed the transverse and hor-
izontal axes, respectively. The volume sweep was saved as
raw data and stored on MODs and sent to the Reading
Center for volume calculations. The volume of analysed
plaque was calculated by delineating the plaque bounda-
ries and the transverse plane (B) using the firmware of
Kretz Ultrasound apparates. This "manual" method
required the object to be manually traced by using the
track ball of the Kretz device. In order to achieve volume
measurement a manual trace was displayed on different
planes of the plaque (Figure 1). The methodology for PV
measurement has been validated previously [14-16].
Quality assessment of central reading
The first set of data consisted of 45 3D US plaque images
with PV ranging from 21 to 240 μl. This data set was used
to compare the results of plaque volume measurements
obtained by 3 trained and certified readers at the Euro-
pean Ultrasound Teaching and Reading Center (EUTARC;
Feldafing, Germany) and to investigate intra- and inter-
reader variability of the reading process. The second data
set consisted of 60 plaque images (PV between 20 and 60
μl) and was used to explore the effect of plaque size and
the number of slices (S) (5 vs. 10 S) in manual planimetry
on the quality of the central reading procedure by a ran-
domly assigned reader.Cardiovascular Ultrasound 2008, 6:42 http://www.cardiovascularultrasound.com/content/6/1/42
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Study protocol and statistical analysis
Sonographic images of the 45 plaques of the first data set
were recorded on video tapes and MODs, and 6 identical
blinded copies were prepared by an independent institu-
tion (Medizinische Software GbR [MESO], Mittweida,
Germany) and named A to F. Three sets of the 45 MODs
were then sent to the Reading Center EUTARC and ran-
domly assigned to 3 appointed readers for subsequent
evaluation. After the measurements from the first round
of reading procedure had been returned to MESO, the
remaining 3 sets of MODs were delivered to the 3 readers
for a second round of readings. Thus, each reader per-
formed two independent evaluations of the 45 MODs
according to a randomized, pre-defined procedure. The
mean of 3 individual readings was used for analysis.
Inter-reader variability was evaluated by comparing the
mean of the first and the second measurement of each
reader between all 3 readers. Assessment of intra-reader
variability was based on comparison between the first and
the second set of measurements of each reader. The intra-
class correlation coefficient (ICC) was applied to assess
inter- and intra-reader variabilities [17]. The ICC is a
measure of the proportion of variance that is attributable
to the objects of measurements, and has emerged as a uni-
versal and widely accepted reliability index [18]. Further-
more, it allows the evaluation of the variability between
more than 2 methods and readers, respectively. Calcula-
tion of the ICC was carried out by means of analysis of
covariance (ANCOVA) using the SAS program (version
9.1). The three ICC values between the first and second set
of measurements of each reader provide an estimation of
intra-reader variability, and the ICC between all 3 readers
Carotid plaque images obtained with 3D US Figure 1
Carotid plaque images obtained with 3D US. The plaque is presented in longitudinal and cross-sectional views. The 3D 
image has been sliced 6 times from one end to the other along the vessel axis in the scan direction.Cardiovascular Ultrasound 2008, 6:42 http://www.cardiovascularultrasound.com/content/6/1/42
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is a measure of inter-reader variability. An additional anal-
ysis was performed after stratification by plaque size (PV
< 60 μl versus PV > 60 μl) as determined in the APRES.
The second data set was used to investigate the effect of
the number of slices in manual planimetry on the quality
of PV measurement. The results of the 5 S- and 10 S-
method were compared by means of the repeatability
coefficient (RC) based on the mean of 3 individual read-
ings per plaque. The RC was calculated as follows [19]: RC
= 1.96 SDDiff, where SDDiff denotes the standard deviation
of the differences in PV measurements between both
methods. If the differences follow a normal distribution,
approximately 5 percent of differences between measure-
ments are expected to lie outside the limits + RC. Variabil-
ity of measurements was investigated by calculating the
coefficient of variation (CV) for 3 individual assessments
of each of the 60 plaques by either method. In order to
analyse the effect of plaque size (PV) on the precision of
measurement, CVs and RC were calculated separately for
smaller plaques (PV between 20 and < 40 μl) and larger
plaques (PV between 40 and 60 μl).
Results
Intra- and inter-reader variability
The results of the PV measurements obtained by the 3
readers for 45 plaques (first data set) are summarised in
Table 1. Mean PV values ranged between 67.8 and 71.8 μl.
The ICC for intra-reader variability were close to 1 (the
highest possible value) for each of the 3 readers with val-
ues of 0.985, 0.967 and 0.969 for the first, second and
third reader, respectively. The ICC value generated
between the 3 readers was 0.964 indicating that inter-
reader variability was small, too (Table 1). Intra- and
inter-reader variabilities were smaller, i.e. ICCs were
higher, for plaques with PV > 60 μl than for plaques with
PV < 60 μl (Table 2).
Effect of number of slices
Mean (SD) PV of the 60 plaques included in the second
data set was 39.8 (11.3) μl for the 5 S-method and 40.1
(11.2) μl for the 10 S-method. Mean (SD) CV calculated
from the 3 individual PV measurements per plaque were
3.4 (1.9)% and 3.1 (1.6)% for the 5 S- and 10 S-methods,
respectively. The RC was 4.7 μl (Table 3). The correspond-
ing differences in PV measurements between the two
methods are depicted by means of a Bland-Altman plot in
Figure 2. A stratified analysis of the 30 plaques with PV
between 20 and < 40 μl and for the 30 plaques between
40 and 60 μl showed that the mean CVs for both the 5 S-
and the 10 S-methods were lower for larger plaques (2.4%
and 2.4%) than for smaller plaques (4.3% and 3.8%).
Discussion
Because carotid plaque progression is not limited to
changes in one direction, it is important to measure pro-
gression in three dimensions. Plaques grow and regress
circumferentially as well as in length and thickness. As a
non-invasive technique, 3D imaging allows:
- direct plaque visualization
- quantification of plaque features
Table 1: Inter- and intra-reader variabilities for re-reading 
plaque volume (PV) of 45 plaques
Reader 1 Reader 2 Reader 3
Intra-reader variability
PV reading 1 (μl) 71.8 (42.5) 67.8 (42.8) 70.1 (45.4)
PV reading 2 (μl) 71.6 (43.3) 70.0 (43.0) 71.5 (44.0)
ICC 0.985 0.967 0.969
Inter-reader variability
PV both readings (μl) 71.7 (42.7) 68.9 (42.2) 70.8 (44.4)
ICC 0.964
Values are mean (standard deviation); ICC, intra-class correlation 
coefficient
Table 2: Intra-class correlation coefficients for re-reading plaque 
volume (PV) of 21 plaques with PV < 60 μl and 24 plaques with 
PV ≥ 60 μl
Reader 1 Reader 2 Reader 3
PV < 60 μl
Intra-reader variability 0.929 0.783 0.689
Inter-reader variability 0.805
PV ≥ 60 μl
Intra-reader variability 0.976 0.960 0.960
Inter-reader variability 0.949
Table 3: Coefficients of variation (CV) and repeatability 
coefficients (RC) for 60 plaques comparing the 5S- and 10S- 
methods
PV (μL) N CV (%) RC (μl)
5S method 10S method 5S vs. 10S
20 to < 40 30 4.3 (2.0) 3.8 (1.9) 3.9
40 to < 60 30 2.4 (1.1) 2.4 (0.9) 5.3
20 to < 60 60 3.4 (1.9) 3.1 (1.6) 4.7
PV, plaque volume
CV was calculated from 3 individual measurements, values are mean 
(standard deviation)
RC was calculated for mean of 3 individual measurements comparing 
5S and 10SCardiovascular Ultrasound 2008, 6:42 http://www.cardiovascularultrasound.com/content/6/1/42
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- the possibility of investigating volume changes that
occur in multiple dimensions, such as plaque surface
morphology, plaque geometry, and plaque distribution.
For these reasons 3D-ultrasound is becoming more
important in serial monitoring of disease progression or
regression. Sample sizes which are required to test the
effects of new therapies might be smaller for measure-
ments of plaque volume than for traditional 2D measure-
ments.
The present study aimed to assess the quality of a central-
ised reading procedure of 3D US recordings of carotid PV
measured in a multinational clinical trial. The small intra-
and inter-reader variabilities reported in the study validate
the reproducibility and reliability of the centralised PV
measurement reading technique. Any slight differences
observed between the 3 appointed readers may have
reflected a minor subjective element due to differences in
practice; however, these differences were small and ran-
domly distributed, and would not be expected to have a
significant effect on results generated in a clinical trial set-
ting. Individual deviations between the first and second
measurement made by the same reader, and between par-
ticipating readers, were comparable with the occurrence of
outliers in other methods of measurement applied in clin-
ical trials, with respect to magnitude and frequency.
In the present study, variability of the re-reading proce-
dure was dependent on plaque size. Both inter- and intra-
reader variabilities were lower for larger than for smaller
plaques. This finding is in agreement with previous PV
variability studies which utilised 3D ultrasound
[1,14,20,21] showing that the CV in the measurement of
PV decreased with plaque size. Due to irregular shape of
some of the atheromatic plaques an increase in the
number of slices used for calculation in manual planime-
try method by decreasing the distance between slices
could possibly increase the accuracy of volume determi-
nations. Therefore, in the present study additional analy-
ses were undertaken on a sample of 60 plaques to assess
the variability depending on plaque size and the number
of slices used during the determination of plaque volume.
Half of plaques were between 20 and < 40 μl and half were
between 40 and < 60 μl. The results indicate that the 5S-
and the 10S-method provided similar results in volume
calculation. Subgroup analyses of the two tracing tech-
niques demonstrated that for the smaller plaques (PV
between 20 and < 40 μl), the 10S-method offered slightly
greater reliability as indicated by a lower coefficient of var-
Difference against average of PV measurements using the 5S- and 10S-methods (second data set, n = 60) Figure 2
Difference against average of PV measurements using the 5S- and 10S-methods (second data set, n = 60).Cardiovascular Ultrasound 2008, 6:42 http://www.cardiovascularultrasound.com/content/6/1/42
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iation. In contrast, there was no difference between relia-
bility of the 5S- or 10S-method in the larger plaque group
(PV between 40 and < 60 μl). Therefore, the reliability of
measurements of smaller plaques (< 40 μl) may be
improved by using the 10S-method.
The small variability in 3D US PV measurements and re-
readings is an important finding, given the fact that this
approach may be useful for evaluating the progression of
carotid atherosclerosis and its response to treatment and
for targeting preventive therapy [12]. Poor reproducibility
could lead to inappropriate clinical management of indi-
vidual patients, particularly given that the ratio of random
measurement error to the variability among progression
rates is large, and repeated measures or longer follow-up
would be required to sufficiently reduce the contributions
of random error to allow individual diagnoses [22].
In contrast to disease areas such as cancer, large-scale
screening programs to identify at-risk individuals with
atherosclerotic disease have not yet been introduced,
despite the higher burden of associated morbidity and
mortality, as highlighted by the recent SHAPE Task Force
Report [23]. The present study has confirmed that a relia-
ble, non-invasive technique for monitoring the progres-
sion or regression (Fig. 3) of carotid atherosclerosis is now
available.
It should be noted that a number of limitations can affect
the 3D technique for measuring plaque volume. In a
Carotid plaque images obtained with 3D US showing an example of plaque regression under therapy with a daily dose of 40 mg  olmesartan Figure 3
Carotid plaque images obtained with 3D US showing an example of plaque regression under therapy with a 
daily dose of 40 mg olmesartan: a) A fibrous non-calcified plaque of the carotid artery (bulb) presented in longitudinal and 
cross sectional views at the start of therapy (Mean volume: 384 μL). b) The same plaque during therapy six months later (Mean 
volume: 250 μL). c) The same plaque (no longer visible) 16 months later.Cardiovascular Ultrasound 2008, 6:42 http://www.cardiovascularultrasound.com/content/6/1/42
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small number of cases, plaque boundaries might not be
well defined due to dropouts and shadowing owing to
attenuation of the US beam, and these might be present in
the reconstructed 3D US images. Calcified plaques with
marked shadowing are not measureable, and plaque iden-
tification at the carotid bifurcation and in areas of poor
image resolution may in a few cases also create some dif-
ficulty in plaque identification. In addition, there is a
higher variability in smaller plaques (< 40 μl), and the
reliability of measurements of smaller plaques (< 40 μl)
may be improved by using an increased number of slices
(10 instead of 5 slices).
In summary, the centralized reading procedure investi-
gated in this study has been shown to be reliable and
reproducible. Variability in the reading process increases
with decreasing plaque volumes, and the 10S-method
may offer greater reproducibility than the 5S-method for
volume assessment of small plaques.
Conclusion
The 3D US techniques combined with a well controlled
centralised reading procedure described in this study are
appropriate tools for monitoring progression of carotid
atherosclerosis and its response to treatment. By imple-
menting standardised central 3D US reading protocols
and strict quality control procedures highly reliable ultra-
sonic re-readings of plaques images can be achieved in
large multicentre trials.
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